Literature DB >> 2310240

Chronic respiratory symptoms and occult gastroesophageal reflux. A prospective clinical study and results of surgical therapy.

T R DeMeester1, L Bonavina, C Iascone, J V Courtney, D B Skinner.   

Abstract

Seventy-seven patients with a primary complaint of persistent cough, wheezing, and/or recurrent pneumonia were evaluated for the presence of occult gastroesophageal reflux disease. Fifty-four patients (70%) had increased esophageal acid exposure on 24-hour pH monitoring of the distal esophagus. In 28% of these patients the respiratory symptoms were thought to be due to aspiration because they occurred during or within 3 minutes after a reflux episode. In the other patients, the respiratory symptoms were either induced by or were unrelated to reflux episodes. The number of respiratory symptoms reported by the patients with increased esophageal acid exposure was directly related to the presence of a nonspecific esophageal motility abnormality (p less than 0.05). This suggested that a motility disorder contributes to aspiration by promoting the aboral flow of refluxed gastric juice. Seventeen patients with increased esophageal acid exposure had an antireflux operation to relieve their respiratory complaints. Patients whose respiratory symptoms induced reflux episodes were not helped by the procedure. Of the other patients, symptoms were abolished by the procedure only in those with normal esophageal motility. It is concluded that the majority of patients suffering from chronic unexplained respiratory symptoms have occult gastroesophageal reflux disease, but only a minority of them are helped by surgery. Carefully performed esophageal function studies are needed to select those patients who will benefit from a surgical antireflux procedure.

Entities:  

Mesh:

Year:  1990        PMID: 2310240      PMCID: PMC1358440          DOI: 10.1097/00000658-199003000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Pulmonary complications of cardiospasm.

Authors:  A S BREAKEY; C T DOTTER; I STEINBERG
Journal:  N Engl J Med       Date:  1951-09-20       Impact factor: 91.245

2.  Antireflux treatment for asthma. Improvement in patients with associated gastroesophageal reflux.

Authors:  P C Harper; A Bergner; M D Kaye
Journal:  Arch Intern Med       Date:  1987-01

3.  Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux.

Authors:  L F Johnson; T R Demeester
Journal:  Am J Gastroenterol       Date:  1974-10       Impact factor: 10.864

4.  Diffuse pulmonary fibrosis and hiatus hernia.

Authors:  J E Pearson; R S Wilson
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

5.  Gastroesophageal reflux and asthma: a possible reflex mechanism.

Authors:  L E Mansfield; M R Stein
Journal:  Ann Allergy       Date:  1978-10

6.  Quantitation of lower esophageal sphincter competence.

Authors:  C S Winans; L D Harris
Journal:  Gastroenterology       Date:  1967-05       Impact factor: 22.682

7.  Esophageal reflux as a trigger in asthma.

Authors:  R H Overholt; R J Voorhees
Journal:  Dis Chest       Date:  1966-05

8.  Assessment of a technique for scintigraphic monitoring of pulmonary aspiration of gastric contents in asthmatics with gastroesophageal reflux.

Authors:  N Ghaed; M R Stein
Journal:  Ann Allergy       Date:  1979-05

9.  Tracheal mucosal damage after aspiration. A scanning electron Microscope study.

Authors:  J W Wynne; R Ramphal; C I Hood
Journal:  Am Rev Respir Dis       Date:  1981-12

10.  Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients.

Authors:  T R DeMeester; L Bonavina; M Albertucci
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

View more
  42 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Asthma and gastroesophageal reflux: fundoplication decreases need for systemic corticosteroids.

Authors:  H Spivak; C D Smith; A Phichith; K Galloway; J P Waring; J G Hunter
Journal:  J Gastrointest Surg       Date:  1999 Sep-Oct       Impact factor: 3.452

Review 3.  Cough. 3: chronic cough and gastro-oesophageal reflux.

Authors:  G A Fontana; M Pistolesi
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

4.  Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Protagonist.

Authors:  L Lundell
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

5.  Does laparoscopic fundoplication provide long-term control of gastroesophageal reflux related cough?

Authors:  C J Allen; M Anvari
Journal:  Surg Endosc       Date:  2004-03-19       Impact factor: 4.584

Review 6.  Gastroesophageal reflux and altered motility in lung transplant rejection.

Authors:  J M Castor; R K Wood; A J Muir; S M Palmer; R A Shimpi
Journal:  Neurogastroenterol Motil       Date:  2010-05-26       Impact factor: 3.598

7.  European multicenter survey on the laparoscopic treatment of gastroesophageal reflux in patients aged less than 12 months with supraesophageal symptoms.

Authors:  G Mattioli; K Bax; F Becmeur; C Esposito; Y Heloury; G Podevin; M Lima; G A MacKinlay; A Goessler; J A Tovar; J Valla; P Tuo; L Nahum; G Ottonello; O Sacco; V Gentilino; A Pini-Prato; E Caponcelli; V Jasonni
Journal:  Surg Endosc       Date:  2005-08-11       Impact factor: 4.584

8.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 9.  Gastro-oesophageal reflux and bronchial asthma: current status and future directions.

Authors:  J L Mathew; M Singh; S K Mittal
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

Review 10.  Cough. 1: Chronic cough in adults.

Authors:  A H Morice; J A Kastelik
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.